159 related articles for article (PubMed ID: 16044416)
1. In vitro evaluation of platelet reactivity toward annuloplasty devices treated with heparin coating: studies under flow conditions.
Tonda R; Galán AM; Pino M; Hernández MR; Ayats C; Pomar JL; Ordinas A; Escolar G
J Biomed Mater Res A; 2005 Oct; 75(1):192-8. PubMed ID: 16044416
[TBL] [Abstract][Full Text] [Related]
2. Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion?
Harig F; Meier C; Hakami L; Strasser R; Bretzger J; Münch F; Vestweber-Wilmes E; Singer H; Weyand M; Cesnjevar R
Thorac Cardiovasc Surg; 2006 Apr; 54(3):168-72. PubMed ID: 16639677
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
4. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
6. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
[TBL] [Abstract][Full Text] [Related]
7. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
Svenmarker S; Häggmark S; Jansson E; Lindholm R; Appelblad M; Sandström E; Aberg T
Scand Cardiovasc J; 2002 Aug; 36(4):241-6. PubMed ID: 12201973
[TBL] [Abstract][Full Text] [Related]
8. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
9. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support.
von Segesser LK
Ann Thorac Surg; 1996 Jan; 61(1):330-5; discussion 340-1. PubMed ID: 8561600
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits.
Hussaini BE; Treanor PR; Healey NA; Tilahun D; Srey R; Lu XG; Khuri SF; Thatte HS
Perfusion; 2009 Sep; 24(5):317-23. PubMed ID: 19965951
[TBL] [Abstract][Full Text] [Related]
11. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of outcome data with regards to the use of Phisio®-, Bioline®- or Softline®-coated cardiopulmonary bypass circuits in cardiac surgery.
Reser D; Seifert B; Klein M; Dreizler T; Hasenclever P; Falk V; Starck C
Perfusion; 2012 Nov; 27(6):530-4. PubMed ID: 22864552
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass.
Zhang K; Hu Z; Yang Y; Huang R; Fan H; Sun Z
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):403-6. PubMed ID: 15015647
[TBL] [Abstract][Full Text] [Related]
14. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
[TBL] [Abstract][Full Text] [Related]
15. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats.
Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H
Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115
[TBL] [Abstract][Full Text] [Related]
17. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
[TBL] [Abstract][Full Text] [Related]
18. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
[TBL] [Abstract][Full Text] [Related]
19. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility.
Tevaearai HT; Mueller XM; Seigneul I; Burki M; Horisberger J; Stumpe F; Von Segesser LK
Int J Artif Organs; 1999 Sep; 22(9):629-34. PubMed ID: 10532432
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of extracorporeal blood treatment. Selection of haemostatic parameters.
Lindhout T
Nephrol Dial Transplant; 1994; 9 Suppl 2():83-9. PubMed ID: 8065621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
